Who owns ADMA Biologics, Inc.?
Institutional ownership of ADMA from SEC Form 13F filings across 215 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
215
13F holders
$1.16B
value, 2026 filers
61.1%
of shares outstanding (141.7M sh)
28
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of ADMA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 38.4M | $321.0M | 0.0% | 16.5% | +4.1% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 10.1M | $84.6M | 0.0% | 4.4% | -51.0% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 10.1M | $84.4M | 0.0% | 4.4% | +13.8% |
| 4 | Capital Research Global Investors | 8.8M | $73.3M | 0.0% | 3.8% | -21.8% |
| 5 | FIRST TRUST ADVISORS LP | 7.8M | $65.3M | 0.0% | 3.4% | +2064.9% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 6.1M | $50.7M | 0.0% | 2.6% | +4.0% |
| 7 | D. E. Shaw & Co., Inc. | 5.3M | $44.1M | 0.0% | 2.3% | +840.5% |
| 8 | GOLDMAN SACHS GROUP INC | 3.5M | $29.4M | 0.0% | 1.5% | +25.3% |
| 9 | Nuveen, LLC | 3.3M | $27.3M | 0.0% | 1.4% | -46.5% |
| 10 | NORTHERN TRUST CORP | 2.4M | $20.2M | 0.0% | 1% | +6.1% |
| 11 | MORGAN STANLEY | 2.3M | $19.0M | 0.0% | 1% | -6.9% |
| 12 | Sixth Street Partners Management Company, L.P.NEW | 2.1M | $17.5M | 3.0% | 0.9% | new |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.1M | $17.5M | 0.0% | 0.9% | -0.2% |
| 14 | TWO SIGMA INVESTMENTS, LP | 2.0M | $16.9M | 0.0% | 0.9% | -3.5% |
| 15 | VANGUARD FIDUCIARY TRUST CO | 1.7M | $13.8M | 0.0% | 0.7% | +1.0% |
| 16 | BANK OF AMERICA CORP /DE/ | 1.6M | $13.8M | 0.0% | 0.7% | -58.8% |
| 17 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.6M | $13,330 | 0.0% | 0.7% | -28.1% |
| 18 | Public Sector Pension Investment Board | 1.6M | $13.3M | 0.0% | 0.7% | +87.0% |
| 19 | BNP PARIBAS FINANCIAL MARKETS | 1.5M | $12.2M | 0.0% | 0.6% | -23.7% |
| 20 | PRINCIPAL FINANCIAL GROUP INC | 1.4M | $11.5M | 0.0% | 0.6% | -0.8% |
| 21 | CITADEL ADVISORS LLC | 1.4M | $11.5M | 0.0% | 0.6% | -76.4% |
| 22 | Qube Research & Technologies Ltd | 1.3M | $11.0M | 0.0% | 0.6% | -28.0% |
| 23 | Bank of New York Mellon Corp | 1.3M | $10.5M | 0.0% | 0.5% | -7.7% |
| 24 | BOOTHBAY FUND MANAGEMENT, LLC | 1.2M | $9.8M | 0.1% | 0.5% | +18.6% |
| 25 | UBS Group AG | 1.2M | $9.8M | 0.0% | 0.5% | -45.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.